Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pertussis booster immunogenicity study in adolescents with different prior pertussis vaccine histories
2005-005532-27Phase 4Completed
- Sponsor
- Sanofi
- Start
- Dec 2005
- Modality
- Whole Inactivated Vaccines → Inactivated Vaccines → Prophylactic Vaccines → Vaccines & Immunotherapeutics, Vaccines & Immunotherapeutics, Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 4, open-label trial of Adacel Polio, COVAXIN and trivalent inactivated polio vaccine in pertussis (3 arms), sponsored by Sanofi. Primary endpoint: Pertussis-specific blood parameters before and one month after booster vaccination. Started Dec 2005; status: completed.
02
Drugs
Adacel PolioCOVAXINtrivalent inactivated polio vaccine
03
Conditions
pertussis
Beyond the preview
Go deeper on 2005-005532-27.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2005-005532-27.